We are live on
!
Find out more
ACH
ArrowMark Colorado Holdings Portfolio holdings
AUM
$3.76B
1-Year Est. Return
21.77%
This Fund
S&P 500
This Quarter
Est. Return
-0.05%
1 Year Est. Return
+21.77%
3 Year Est. Return
+58.74%
5 Year Est. Return
+55.15%
10 Year Est. Return
+474.07%
AUM
$12.8B
AUM Growth
-$503M
(-3.8%)
Cap. Flow
-$241M
Cap. Flow
% of AUM
-1.88%
Top 10 Holdings %
Top 10 Hldgs %
22.58%
Holding
382
New
39
Increased
93
Reduced
133
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invivyd
IVVD
|
+$103M |
| 2 |
N-able
NABL
|
+$75.2M |
| 3 |
Purple Innovation
PRPL
|
+$66.2M |
| 4 |
Frontdoor
FTDR
|
+$60.9M |
| 5 |
MNTV
Momentive Global Inc. Common Stock
MNTV
|
+$58.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PFPT
Proofpoint, Inc.
PFPT
|
+$193M |
| 2 |
Gartner
IT
|
+$90.6M |
| 3 |
WIX.com
WIX
|
+$84.6M |
| 4 |
MNDT
Mandiant, Inc. Common Stock
MNDT
|
+$58.6M |
| 5 |
Neurocrine Biosciences
NBIX
|
+$54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.28% |
| 2 | Industrials | 21.22% |
| 3 | Technology | 18.95% |
| 4 | Consumer Discretionary | 13.7% |
| 5 | Communication Services | 5.93% |
Similar funds
SCA
VA
DGM
VVP
ABC
SAI
GL
GCC
ArrowMark Colorado Holdings's Q3 2021 Portfolio in Review
As of Q3 2021, ArrowMark Colorado Holdings held 382 positions worth $12.8B, down 3.8% from $13.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
ArrowMark Colorado Holdings's Q3 2021 filing shows 39 new, 93 increased, 133 reduced and 24 closed positions. Its largest new stake was Invivyd: 2,772,927 shares worth $117M. The largest sale was Proofpoint, Inc., an estimated $193M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Industrials and Technology.
- ArrowMark Colorado Holdings's largest Q3 2021 buy was Invivyd: 2,772,927 shares worth $117M.
- ArrowMark Colorado Holdings added most to Purple Innovation in Q3 2021, an estimated $66.2M increase.
- ArrowMark Colorado Holdings's biggest Q3 2021 reduction was Neurocrine Biosciences, cutting an estimated $54M.
- ArrowMark Colorado Holdings fully exited Proofpoint, Inc. in Q3 2021, selling an estimated $193M.
- ArrowMark Colorado Holdings's ten largest holdings make up 23% of its $12.8B portfolio in Q3 2021.
- ArrowMark Colorado Holdings opened 39 new positions and closed 24 in Q3 2021.
- ArrowMark Colorado Holdings's portfolio value fell 3.8% quarter-over-quarter to $12.8B.
Based on ArrowMark Colorado Holdings's 13F filing for Q3 2021, filed 15 Nov 2021.